Shandong Xinhua Pharmaceutical Company Limited Inventory

The latest inventory for 0719.HK is $1.3B as of June 2026. That compares with $1.2B in the prior-year period — up 5.4% year over year. Investors often review this figure alongside Shandong Xinhua Pharmaceutical Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 0719.HK's inventory moved from $1.2B to $1.3B — a 5.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shandong Xinhua Pharmaceutical Company Limited's operating scale or balance-sheet position.

A inventory figure of $1.3B for 0719.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 0719.HK's inventory ($1.3B), review year-over-year change from $1.2B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.